Literature DB >> 5298342

Studies on kallikrein: failure of some anti-inflammatory drugs to affect release of kinin.

G E Davies, G Holman, T P Johnston, J S Lowe.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5298342      PMCID： PMC1510866          DOI： 10.1111/j.1476-5381.1966.tb01887.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  9 in total

1.  [PARTIAL PURIFICATION AND PROPERTIES OF A KININOGEN FROM BOVINE BLOOD].

Authors:  E HABERMANN; W KLETT; G ROSENBUSCH
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1963

2.  PURIFICATION OF BOVINE BRADYKININOGEN.

Authors:  T SUZUKI; Y MIZUSHIMA; T SATO; S IWANAGA
Journal:  J Biochem       Date:  1965-01       Impact factor: 3.387

3.  A STABLE SUBSTRATE FOR THE ASSAY OF PLASMA KININ-FORMING ENZYMES.

Authors:  E AMUNDSEN; K NUSTAD; B WAALER
Journal:  Br J Pharmacol Chemother       Date:  1963-12

4.  The effects of guinea-pig gamma globulins on capillary permeability and serum complement.

Authors:  G E DAVIES; J S LOWER
Journal:  Immunology       Date:  1961-10       Impact factor: 7.397

5.  Analgesic-antipyretic drugs as inhibitors of kallikrein.

Authors:  B J NORTHOVER; G SUBRAMANIAN
Journal:  Br J Pharmacol Chemother       Date:  1961-08

6.  Active polypeptides derived from plasma proteins.

Authors:  G P LEWIS
Journal:  Physiol Rev       Date:  1960-10       Impact factor: 37.312

7.  The mechanism of the functional hyperaemia in the submandibular salivary gland.

Authors:  S M HILTON; G P LEWIS
Journal:  J Physiol       Date:  1955-08-29       Impact factor: 5.182

8.  Indomethacin, a new anti-inflammatory drug: its potential use as a laboratory tool.

Authors:  M N Walters; D A Willoughby
Journal:  J Pathol Bacteriol       Date:  1965-10

9.  PRESENCE OF KALLIKREIN IN THE GAMMA-GLOBULIN PERMEABILITY FACTOR OF GUINEA-PIG SERUM.

Authors:  G E DAVIES; J S LOWE
Journal:  Br J Pharmacol Chemother       Date:  1963-12
  9 in total
  5 in total

1.  Anti-inflammatory synergy of MEN16132, a kinin B(2) receptor antagonist, and dexamethasone in carrageenan-induced knee joint arthritis in rats.

Authors:  C Valenti; S Giuliani; C Cialdai; M Tramontana; C A Maggi
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

3.  Mediators of the inflammatory response and their modification by therapeutic agents.

Authors:  D A Willoughby
Journal:  Proc R Soc Med       Date:  1967-08

4.  Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).

Authors:  H Saito; O D Ratnoff; R Waldmann; J P Abraham
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

5.  Kinins and anti-inflammatory steroids.

Authors:  V Eisen; L Greenbaum; G P Lewis
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.